Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Horst

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Inflammatory Bowel Diseases|January 12, 2016
Patients with Refractory Crohn's Disease Successfully Treated with UstekinumabKimberly A Harris, Sara Horst, Akash Gadani, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 22, 2005
Pharmacokinetics and clinical evaluation of 125I-radiolabeled humanized CC49 monoclonal antibody (HuCC49deltaC(H)2) in recurrent and metastatic colorectal cancer patientsJim Xiao, Sara Horst, George Hinkle, et al.
Digestive Diseases and Sciences|September 19, 2023
Insurance Approval Delay of Biologic Therapy Dose Escalation Associated with Disease Activity in Patients with Inflammatory Bowel DiseaseNisha B Shah, Autumn D Zuckerman, Katie R Hosteng, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 1, 2017
Novel pathologic scoring tools predict end-stage kidney disease in light chain (AL) amyloidosisSamuel Rubinstein, Robert F Cornell, Liping Du, et al.
Digestive Diseases and Sciences|October 3, 2014
Treatment with immunosuppressive therapy may improve depressive symptoms in patients with inflammatory bowel diseaseSara Horst, Andrew Chao, Michael Rosen, et al.
Digestive Diseases and Sciences|February 27, 2021
Mucosal Integrity Testing Can Detect Differences in the Rectums of Patients with Inflammatory Bowel Disease Compared to Controls: A Pilot StudyMiles Basil, David Schwartz, Robin Dalal, et al.
Crohn'S & Colitis 360|March 24, 2020
A Single Center Experience With Long-Term Ustekinumab Use and Reinduction in Patients With Refractory Crohn DiseaseAudrey Bennett, Lauren Evers Carlini, Caroline Duley, et al.
Crohn'S & Colitis 360|December 11, 2025
Successful Collection of Patient-Reported Outcomes Shows Improvement in Quality of Life, Depression, and Disease Activity among Patients with Inflammatory Bowel Disease: A Real-World StudyCihang Gu, Audrey Bennett, Justin Bachmann, et al.
Inflammatory Bowel Diseases|May 17, 2021
The Importance of Monitoring the Postpartum Period in Moderate to Severe Crohn's DiseaseAudrey Bennett, Alexander Mamunes, Mindy Kim, et al.
Inflammatory Bowel Diseases|July 17, 2024
Concomitant Administration of Ozanimod and Serotonergic Antidepressants in Patients With Ulcerative Colitis or Relapsing Multiple SclerosisMiguel Regueiro, Britta Siegmund, Sara Horst, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Inflammatory Bowel Diseases|January 12, 2016
Patients with Refractory Crohn's Disease Successfully Treated with UstekinumabKimberly A Harris, Sara Horst, Akash Gadani, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 22, 2005
Pharmacokinetics and clinical evaluation of 125I-radiolabeled humanized CC49 monoclonal antibody (HuCC49deltaC(H)2) in recurrent and metastatic colorectal cancer patientsJim Xiao, Sara Horst, George Hinkle, et al.
Digestive Diseases and Sciences|September 19, 2023
Insurance Approval Delay of Biologic Therapy Dose Escalation Associated with Disease Activity in Patients with Inflammatory Bowel DiseaseNisha B Shah, Autumn D Zuckerman, Katie R Hosteng, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 1, 2017
Novel pathologic scoring tools predict end-stage kidney disease in light chain (AL) amyloidosisSamuel Rubinstein, Robert F Cornell, Liping Du, et al.
Digestive Diseases and Sciences|October 3, 2014
Treatment with immunosuppressive therapy may improve depressive symptoms in patients with inflammatory bowel diseaseSara Horst, Andrew Chao, Michael Rosen, et al.
Digestive Diseases and Sciences|February 27, 2021
Mucosal Integrity Testing Can Detect Differences in the Rectums of Patients with Inflammatory Bowel Disease Compared to Controls: A Pilot StudyMiles Basil, David Schwartz, Robin Dalal, et al.
Crohn'S & Colitis 360|March 24, 2020
A Single Center Experience With Long-Term Ustekinumab Use and Reinduction in Patients With Refractory Crohn DiseaseAudrey Bennett, Lauren Evers Carlini, Caroline Duley, et al.
Crohn'S & Colitis 360|December 11, 2025
Successful Collection of Patient-Reported Outcomes Shows Improvement in Quality of Life, Depression, and Disease Activity among Patients with Inflammatory Bowel Disease: A Real-World StudyCihang Gu, Audrey Bennett, Justin Bachmann, et al.
Inflammatory Bowel Diseases|May 17, 2021
The Importance of Monitoring the Postpartum Period in Moderate to Severe Crohn's DiseaseAudrey Bennett, Alexander Mamunes, Mindy Kim, et al.
Inflammatory Bowel Diseases|July 17, 2024
Concomitant Administration of Ozanimod and Serotonergic Antidepressants in Patients With Ulcerative Colitis or Relapsing Multiple SclerosisMiguel Regueiro, Britta Siegmund, Sara Horst, et al.
Pageof 5